The National Academies
Health and Medicine Division
Explore by Topic
Biomedical and Health Research
Children and Families
Food and Nutrition
Health Care Workforce
Health Services, Coverage, and Access
Quality and Patient Safety
Select Populations and Health Equity
Substance Use and Mental Health
Military and Veterans Health
Displaying: 1 to 10 of 367 Meetings
Health Literacy and Communication Strategies in Oncology: A Workshop
Date: July 15, 2019 - July 16, 2019 (8:00 AM Eastern)
Health literacy is the degree to which individuals can access, comprehend, and use information to make health care decisions. However, estimates suggest that more than one-third of the U.S. adult population has low health literacy. Inadequate health literacy can make it difficult for individuals to engage in healthy behaviors and navigate the health care system across the cancer care continuum. To consider opportunities to improve communication in cancer prevention and care, as well as to better support individuals with low health literacy, the Forum is collaborating with the Roundtable on Health Literacy to host a workshop on this topic.
Meeting 4: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action
Date: July 9, 2019 (9:30 AM Eastern)
The Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session for the public on Tuesday, July 9, 2019.
Public Webinar Release: Guiding Cancer Control: A Path to Transformation
Date: June 27, 2019 (1:00 PM Eastern)
Please join us to learn about a new report by the National Academies' ad hoc Committee on a National Strategy for Cancer Control in the United States. The webinar will include an overview of the report and discussion of the report’s findings, conclusions, recommendations, and key messages.
Breaking Down Silos: The Convergence of Infectious Diseases and Noncommunicable Diseases – A Workshop
Date: June 11, 2019 - June 12, 2019 (1:00 PM Eastern)
This is a 1.5-day workshop that will explore the growing understanding of how microbes interact with and affect humans in multiple ways, ranging from affecting normal physiological functions to chronic diseases. The workshop will allow participants to gain a deeper understanding of how the distinction between infectious diseases and noncommunicable diseases is blurring and how this is extending to new approaches, such as the use of vaccination to treat certain cancers.
Meeting 3: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action
Date: June 3, 2019 (1:00 PM Eastern)
The NASEM Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session to hear from experts in the SCD community on Monday, June 3, 2019.
Advancing Gene-Targeted Therapies for Central Nervous System Disorders: A Workshop
Date: April 23, 2019 - April 24, 2019 (1:30 PM Eastern)
On April 23 and 24, 2019, the Forum on Neuroscience and Nervous System Disorders will host a public workshop that will bring together experts and key stakeholders from academia, government, industry, and non-profit organizations to explore approaches for advancing the development of gene-targeted therapies for central nervous system (CNS) disorders.
Meeting 2: Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action
Date: April 16, 2019 (9:30 AM Eastern)
The Committee on Addressing Sickle Cell Disease: A Strategic Blueprint and Plan for Action will hold an open session for the public on Tuesday, April 16, 2019.
Meeting #2: Identifying Disabling Medical Conditions Likely to Improve with Treatment
Date: April 16, 2019 - April 17, 2019 (9:00 AM Eastern)
Improving Access to and Equity of Care for People with Serious Illness: A Workshop
Date: April 4, 2019 (8:00 AM Eastern)
The workshop will examine access to and equity of care for people with serious illness
Updating Labels for Generic Oncology Drugs: A Workshop
Date: March 26, 2019 (8:00 AM Eastern)
The National Cancer Policy Forum will hold a public workshop on Tuesday, March 26th, 2019 on Updating Labels for Generic Oncology Drugs. This workshop will convene expert stakeholders to discuss the challenges and opportunities to update generic oncology drugs labels that are inconsistent with the current evidence base and use in clinical practice. Discussions will focus primarily on considering the potential data sources and evidence requirements for adding new indications to outdated labels, including indications for select patient populations (such as pediatric oncology).